India, March 24 -- Acquisition to strengthen Eris' metabolic and women's health segments

Eris Lifesciences announced the acquisition of the prescription probiotics business of Velbiom Probiotics (Velbiom) for a consideration of Rs 50 crore. The strategic move strengthens Eris' franchises in Metabolic Wellness and Women's Healthcare. Velbiom is a science-driven bio-therapeutics company committed to the advancement of India-specific microbiome based therapy and research. It is India's first exclusive probiotic company with a wide range of disease specific, strain specific and site-specific probiotic formulations.

Key brands acquired as part of the deal:

Lactogut - Multi-strain gastrointestinal health formulationLactogut UG -Recurrent UTI...